{"id":201830,"name":"VALNEVA AUSTRIA GMBH","slug":"valneva-austria-gmbh","state":null,"country":"Austria","description":"Pharmaceutical company working on the research, development, and manufacture of vaccines.","totalSpending":680000,"filings":18,"yearlySpending":[{"year":2018,"income":10000},{"year":2019,"income":160000},{"year":2020,"income":180000},{"year":2021,"income":170000},{"year":2022,"income":160000}],"issues":[{"code":"BUD","display":"Budget/Appropriations"},{"code":"PHA","display":"Pharmacy"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"HCR","display":"Health Issues"}],"firms":["MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC)"],"lobbyists":["JOHN MILNE","JEFFREY WIENER","ALLEN SHOFE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues related to the prevention and treatment of tick-born illness, including Lyme Disease","Issues related to the prevention and treatment of tick-born illness, including Lyme Disease","Issues related to the prevention and treatment of tick-born illness, including Lyme Disease","Advocating for R&D funding for Lyme Disease vaccine programs","FY2020 Labor-HHS-Education Appropriations Related to the research and development of Lyme Disease vaccine programs within the Department of Health and Human Services/NIAID."]}